Search Results - "Hanes, Sarah J"

Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets by Tanenbaum, Molly L, Hanes, Sarah J, Miller, Kellee M, Naranjo, Diana, Bensen, Rachel, Hood, Korey K

“…Diabetes devices (insulin pumps, continuous glucose monitors [CGMs]) are associated with benefits for glycemic control, yet uptake of these devices continues…”
Get full text

Satisfaction with diabetes involvement: Exploring parent and adolescent perspectives by Wong, Jessie J, Hanes, Sarah J, Flores, Haley, Ngo, Jessica, Hood, Korey K

“…Both parent and adolescent involvement in type 1 diabetes management are critical during adolescence. The current study sought to understand the factors…”
Get full text

Psychosocial Effects of the Loop Open-Source Automated Insulin Delivery System by Wong, Jessie J., Hood, Korey K., Hanes, Sarah J., Lal, Rayhan A., Naranjo, Diana

“…Aims: This study examined the psychosocial impact of Loop, an open-source automated insulin dosing system that has emerged from the diabetes technology…”
Get full text

Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System by Suttiratana, Sakinah C, Wong, Jessie J, Lanning, Monica S, Dunlap, Adrienne, Hanes, Sarah J, Hood, Korey K, Lal, Rayhan A, Naranjo, Diana

“…Loop is an open-source automated insulin delivery (AID) system, used by more than 9,000 people with type 1 diabetes. Understanding the pros and cons of Loop…”
Get more information

Trust in hybrid closed loop among people with diabetes: Perspectives of experienced system users by Tanenbaum, Molly L, Iturralde, Esti, Hanes, Sarah J, Suttiratana, Sakinah C, Ambrosino, Jodie M, Ly, Trang T, Maahs, David M, Naranjo, Diana, Walders-Abramson, Natalie, Weinzimer, Stuart A, Buckingham, Bruce A, Hood, Korey K

“…Automated closed loop systems will greatly change type 1 diabetes management; user trust will be essential for acceptance of this new technology. This…”
Get full text

Implementation of Depression Screening and Global Health Assessment in Pediatric Subspecialty Clinics by Iturralde, Esti, Adams, Rebecca N., Barley, Regan C., Bensen, Rachel, Christofferson, Megan, Hanes, Sarah J., Maahs, David M., Milla, Carlos, Naranjo, Diana, Shah, Avni C., Tanenbaum, Molly L., Veeravalli, Sruthi, Park, K.T., Hood, Korey K.

“…Adolescents with chronic illness face greater risk of psychosocial difficulties, complicating disease management. Despite increased calls to screen for…”
Get full text

Diabetes Device Satisfaction Among Adolescents Living With Type 1 Diabetes and Their Parents by Wong, Jessie J., Alamarie, Selma A., Hanes, Sarah J., Flores, Haley, Ngo, Jessica, Schneider-Utaka, Aika K., Hood, Korey K.

“…Background: Diabetes technologies are valuable tools to reduce burden and enhance glycemic control, especially during adolescence. The current study sought to…”
Get full text

ONBOARD: A Feasibility Study of a Telehealth-Based Continuous Glucose Monitoring Adoption Intervention for Adults with Type 1 Diabetes by Tanenbaum, Molly L, Ngo, Jessica, Hanes, Sarah J, Basina, Marina, Buckingham, Bruce A, Hessler, Danielle, Maahs, David M, Mulvaney, Shelagh, Hood, Korey K

“…Continuous glucose monitoring (CGM) can improve glycemic control for adults with type 1 diabetes (T1D) but certain barriers interfere with consistent use…”
Get more information

From Wary Wearers to d-Embracers: Personas of Readiness to Use Diabetes Devices by Tanenbaum, Molly L., Adams, Rebecca N., Iturralde, Esti, Hanes, Sarah J., Barley, Regan C., Naranjo, Diana, Hood, Korey K.

“…Background: Diabetes devices such as insulin pumps and continuous glucose monitoring (CGM) are associated with improved health and quality of life in adults…”
Get full text

Discontinued Use of the Loop Insulin Dosing System: A Mixed-Methods Investigation by Wong, Jessie J, Suttiratana, Sakinah C, Lal, Rayhan A, Lum, John W, Lanning, Monica S, Dunlap, Adrienne, Arbiter, Brandon, Hanes, Sarah J, Bailey, Ryan J, Hood, Korey K, Naranjo, Diana

“…Loop is an open-source automated insulin dosing system that allows users unrivaled control over system settings that affect future glucose prediction…”
Get more information

Optimal Use of Diabetes Devices: Clinician Perspectives on Barriers and Adherence to Device Use by Tanenbaum, Molly L., Adams, Rebecca N., Hanes, Sarah J., Barley, Regan C., Miller, Kellee M., Mulvaney, Shelagh A., Hood, Korey K.

“…Background: Insulin pumps and continuous glucose monitors (CGM) can improve glycemic control for individuals with type 1 diabetes (T1D). Device uptake rates…”
Get full text

Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management by Adams, Rebecca N, Tanenbaum, Molly L, Hanes, Sarah J, Ambrosino, Jodie M, Ly, Trang T, Maahs, David M, Naranjo, Diana, Walders-Abramson, Natalie, Weinzimer, Stuart A, Buckingham, Bruce A, Hood, Korey K

“…Hybrid closed loop (HCL) systems are designed to automate insulin delivery to improve type 1 diabetes (T1D) outcomes and reduce user burden and distress…”
Get more information

Expanding the use of patient-reported outcomes (PROs): Screening youth with type 1 diabetes from underrepresented populations by Addala, Ananta, Wong, Jessie J., Penaranda, Ricardo Medina, Hanes, Sarah J., Abujaradeh, Hiba, Adams, Rebecca N., Barley, Regan C., Iturralde, Esti, Lanning, Monica S., Tanenbaum, Molly L., Naranjo, Diana, Hood, Korey K.

“…Youth from lower socioeconomic status (SES) have suboptimal type 1 diabetes (T1D) outcomes. Patient reported outcomes (PROs) measure psychosocial states and…”
Get full text

Using Cluster Analysis to Understand Clinician Readiness to Promote Continuous Glucose Monitoring Adoption by Tanenbaum, Molly L., Adams, Rebecca N., Lanning, Monica S., Hanes, Sarah J., Agustin, Bianca I., Naranjo, Diana, Hood, Korey K.

“…Background: Many people with type 1 diabetes (T1D) report barriers to using continuous glucose monitoring (CGM). Diabetes care providers may have their own…”
Get full text

Depression in context: Important considerations for youth with type 1 vs type 2 diabetes by Wong, Jessie J., Addala, Ananta, Abujaradeh, Hiba, Adams, Rebecca N., Barley, Regan C., Hanes, Sarah J., Iturralde, Esti, Lanning, Monica S., Naranjo, Diana, Tanenbaum, Molly L., Hood, Korey K.

“…Background Youth with diabetes are at increased risk for depression. However, severity and correlates of depressive symptoms may differ by diabetes type…”
Get full text

DiabetesWise: An innovative approach to promoting diabetes device awareness by Wong, Jessie J, Addala, Ananta, Hanes, Sarah J, Krugman, Sara, Naranjo, Diana, Nelmes, Sierra, Rose, Kyle Jacques, Tanenbaum, Molly L, Hood, Korey K

“…DiabetesWise is an unbranded, data-driven online resource that tailors device recommendations based on preferences and priorities of people with…”
Get full text

Diabetes wise:提高糖尿病器械认知度的创新方法 by Wong, Jessie J, Addala, Ananta, Hanes, Sarah J, Krugman, Sara, Naranjo, Diana, Nelmes, Sierra, Rose, Kyle Jacques, Tanenbaum, Molly L, Hood, Korey K

“…摘要 背景:DiabetesWise是一个无品牌的, 以数据驱动的在线资源, 根据胰岛素需求者的偏好和优先事项, 量身定制设备推荐。本研究的目的是研究DiabetesWise是否能增加胰岛素需求者使用胰岛素治疗设备的比率, 这些设备经过实证支持可改善血糖和心理社会结果。…”
Get full text

Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting by Ekhlaspour, Laya, Nally, Laura M., El-Khatib, Firas H., Ly, Trang T., Clinton, Paula, Frank, Eliana, Tanenbaum, Molly L., Hanes, Sarah J., Selagamsetty, Rajendranath R., Hood, Korey, Damiano, Edward R., Buckingham, Bruce A.

“…Background: We tested the safety and performance of the “insulin-only” configuration of the bionic pancreas (BP) closed-loop blood-glucose control system in a…”
Get full text

Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System by Iturralde, Esti, Tanenbaum, Molly L., Hanes, Sarah J., Suttiratana, Sakinah C., Ambrosino, Jodie M., Ly, Trang T., Maahs, David M., Naranjo, Diana, Walders-Abramson, Natalie, Weinzimer, Stuart A., Buckingham, Bruce A., Hood, Korey K.

“…Purpose The first hybrid closed loop (HCL) system, which automates insulin delivery but requires user inputs, was approved for treatment of type 1 diabetes…”
Get full text